Showing 1 - 10 of 15
Persistent link: https://www.econbiz.de/10010485559
Persistent link: https://www.econbiz.de/10003193758
Persistent link: https://www.econbiz.de/10003718171
Persistent link: https://www.econbiz.de/10011294610
Persistent link: https://www.econbiz.de/10011409439
Persistent link: https://www.econbiz.de/10011713223
Persistent link: https://www.econbiz.de/10011713225
Drugs like bevacizumab ($50,000 per treatment episode) and ipilimumab ($120,000 per episode) have fueled the perception that the launch prices of anticancer drugs are increasing over time. Using an original dataset of 58 anticancer drugs approved between 1995 and 2013, we find that launch...
Persistent link: https://www.econbiz.de/10012457799
This paper investigates the impact of depression on labor force participation among older workers. Empirically, we use two analytic strategies and rely on a sample drawn from the Health and Retirement Survey. Depression directly and indirectly increases individuals' probability of retiring early...
Persistent link: https://www.econbiz.de/10012466431
The US Food and drug Administration (FDA) is estimated to regulate markets accounting for about 20% of consumer spending in the US. This paper proposes a general methodology to evaluate FDA policies, in general, and the central speed-safety tradeoff it faces, in particular. We apply this...
Persistent link: https://www.econbiz.de/10012466948